The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of baseline IL-8 and ferritin with clinical outcome with everolimus and BNC105P in the DisrupTOR-1 trial.
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Arun Azad
No Relationships to Disclose
 
Sumeet Bhatia
No Relationships to Disclose
 
Harry A. Drabkin
No Relationships to Disclose
 
Brian Addis Costello
No Relationships to Disclose
 
John Sarantopoulos
No Relationships to Disclose
 
Ravindran Kanesvaran
No Relationships to Disclose
 
Richard C. Lauer
No Relationships to Disclose
 
Christopher Sweeney
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Speakers' Bureau - Medivation
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Fluidigm (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bionomics; Millennium
 
Guru Sonpavde
No Relationships to Disclose
 
Stephen Lane Richey
No Relationships to Disclose
 
Timothy Breen
No Relationships to Disclose
 
Gabriel Kremmidiotis
Employment - Bionomics
 
Annabell F. Leske
Employment - Bionomics
 
Elizabeth E. Doolin
Employment - Bionomics
 
David C. Bibby
Employment - Bionomics
 
Jeremy Andrew Simpson
Employment - Bionomics
 
Jose Luis Iglesias
Employment - Bionomics
 
Thomas E. Hutson
Employment - Texas Oncology
Honoraria - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; GlaxoSmithKline; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Pfizer
Research Funding - GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Medivation (Inst); Pfizer (Inst)